# IUTRS Alzheimer Treatment Efficiency

A data analysis of a pharmaceutical company's new treatment option
for the Alzheimer Disease. This data is tested against two different
dosages, and, a placebo.

This study is taken over 88 weeks and several medical examinations,
on 102 pseudonymized patients.

The objective of this work is to submit a statistical report studying
the efficiency of this new treatment option, and, to classify the profile
of some of the patients.

